mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process
International Journal of Molecular Sciences · 02.06.2024 · 25 (11) · 6141
DOI: 10.3390/ijms25116141 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.06.2024. Verfasst von Sulaiman K Marafie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, P.O. Box 1180, Dasman 15462, Kuwait. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Neoplasms, Metabolic Diseases, Aging. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The mammalian target of rapamycin (mTOR) is a pivotal regulator, integrating diverse environmental signals to control fundamental cellular functions, such as protein synthesis, cell growth, survival, and apoptosis. Embedded in a complex network of signaling pathways, mTOR dysregulation is implicated in the onset and progression of a range of human diseases, including metabolic disorders such as diabetes and cardiovascular diseases, as well as various cancers. mTOR also has a notable role in aging. Given its extensive biological impact, mTOR signaling is a prime therapeutic target for addressing these complex conditions. The development of mTOR inhibitors has proven advantageous in numerous research domains. This review delves into the significance of mTOR signaling, highlighting the critical components of this intricate network that contribute to disease. Additionally, it addresses the latest findings on mTOR inhibitors and their clinical implications. The review also emphasizes the importance of developing more effective next-generation mTOR inhibitors with dual functions to efficiently target the mTOR pathways. A comprehensive understanding of mTOR signaling will enable the development of effective therapeutic strategies for managing diseases associated with mTOR dysregulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, P.O. Box 1180, Dasman 15462, Kuwait.
- Department of Translational Research, Dasman Diabetes Institute, P.O. Box 1180, Dasman 15462, Kuwait.
ORCID-Profile: Sulaiman K Marafie, Fahd Al-Mulla, Jehad Abubaker
Zitieren
APA
Marafie, S. K., Al-Mulla, F., & Abubaker, J. (2024). mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process. International Journal of Molecular Sciences, 25(11), 6141. https://doi.org/10.3390/ijms25116141
Vancouver
Marafie SK, Al-Mulla F, Abubaker J. mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process. International Journal of Molecular Sciences. 2024;25(11):6141. doi:10.3390/ijms25116141
BibTeX
@article{Marafie2024,
author = {Marafie, Sulaiman K and Al-Mulla, Fahd and Abubaker, Jehad},
title = {mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {11},
pages = {6141},
doi = {10.3390/ijms25116141}
}
EUVIMED